Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer

Table 1

General data of patients included in the research.

Indicators	Values
Age (years)	62.8 ± 6.5
BMI (kg/m^2)	21.5 ± 0.7
PSA (ng/mL)	69.8 ± 10.4
Duration of diseases (years)	2.5 ± 0.6
BPH (n)	23
Intraepithelial neoplasia (n)	2
Prostatitis (n)	4
Prostate cancer (n)	43
Hyperlipidemia (n)	12
Hypertension (n)	15
Diabetes (n)	18

BPH: benign prostatic hyperplasia, PSA: prostate specific antigen, BMI: body mass index.